13F Holdings
中文EN

CAMP Camp4 Therapeutics Corp

Pharmaceutical Preparations · Nasdaq · SEC CIK 1736730 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY39.9%
TTM net income YoY-126.8%
TTM EPS YoY-103.3%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin-1,001.1%
Net margin-2,276.3%
FCF margin-496.4%
EBITDA margin-965.5%

Returns

ROE-146.1%
ROA-109.9%
ROIC (approx.)—
Asset turnover0.05x

Leverage & solvency

Liabilities / assets20.1%
Debt / equity0.00x
Current ratio6.42x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.21x
Accruals ratio-86.7%
Payout ratio—
Capex / revenue16.3%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31
Income statement
Revenue$3.50M$652,000$350,000
R&D expense$38.20M$38.82M$40.62M
SG&A expense$17.36M$14.92M$11.61M
Operating income-$52.55M-$53.09M-$51.88M
Income tax$0$0$0
Net income-$80.40M-$51.79M-$49.29M
EBITDA-$50.92M-$51.39M-$50.20M
EPS (basic)-2.65-11.04-124.80
EPS (diluted)-2.65-11.04-124.80
Dividends declared per share0.000.00—
Weighted avg. shares (diluted)30.38M4.69M394,976
Balance sheet
Cash & equivalents$109.52M$65.66M$40.00M
Current assets$114.09M$66.38M$40.01M
PP&E, net$2.34M$3.86M$4.80M
Total assets$117.81M$78.31M$54.95M
Current liabilities$15.51M$9.60M$7.81M
Total liabilities$70.10M$15.16M$16.53M
Shareholders' equity$47.70M$63.14M-$123.73M
Shares outstanding51.90M20.15M460,704
Cash flow statement
Operating cash flow-$29.55M-$45.56M-$44.16M
Capital expenditure$279,000$441,000$678,000
Free cash flow-$29.83M-$46.00M-$44.83M
Investing cash flow-$243,000-$441,000-$678,000
Financing cash flow$75.89M$71.66M$301,000
Depreciation & amortization$1.64M$1.70M$1.68M
Stock-based compensation$4.00M$4.03M$2.91M

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.